PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsChloramphenicol
Chloramphenicol
Chlorofair, Chloromycetin, Chloromyxin, Chloroptic, Chloroptic-p, Econochlor, Mychel-s, Ophthochlor, Ophthocort, Optomycin (chloramphenicol) is a small molecule pharmaceutical. Chloramphenicol was first approved as Chloroptic on 1982-01-01. It is used to treat bacterial eye infections, bacterial infections, bacteroides infections, haemophilus infections, and meningococcal meningitis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
otorhinolaryngologic diseasesD010038
nervous system diseasesD009422
eye diseasesD005128
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Chloramphenicol
Tradename
Company
Number
Date
Products
CHLOROPTICAllerganN-050091 DISCN1982-01-01
1 products
CHLOROMYCETINPfizerN-050153 DISCN1982-01-01
1 products
CHLOROMYCETINPfizerN-050183 DISCN1982-01-01
1 products
CHLOROMYCETINParkedale PharmaceuticalsN-050143 DISCN1982-01-01
1 products
CHLOROMYCETINParkedale PharmaceuticalsN-050156 DISCN1982-01-01
1 products
CHLOROMYCETINParkedale PharmaceuticalsN-050205 DISCN1982-01-01
1 products
Hide discontinued
Chloramphenicol
+
Hydrocortisone acetate
Tradename
Company
Number
Date
Products
CHLOROMYCETIN HYDROCORTISONEParkedale PharmaceuticalsN-050202 DISCN1982-01-01
1 products
Hide discontinued
Chloramphenicol
+
Hydrocortisone acetate
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
OPHTHOCORTParkedale PharmaceuticalsN-050201 DISCN1982-01-01
1 products
Hide discontinued
Chloramphenicol
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
CHLOROMYXINPfizerN-050203 DISCN1982-01-01
1 products
Hide discontinued
Chloramphenicol sodium succinate
Tradename
Company
Number
Date
Products
CHLOROMYCETINParkedale PharmaceuticalsN-050155 DISCN1982-01-01
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
chloramphenicol sodium succinateANDA2019-12-31
chloromycetin2006-10-08
mychelle dermaceuticals replenishing solar defenseOTC monograph final2019-02-22
mychelle dermaceuticals replenishing solar defense bodyOTC monograph final2019-02-22
mychelle dermaceuticals replenishing solar defense body spf 50OTC monograph final2022-01-06
mychelle dermaceuticals replenishing solar defense spf 30OTC monograph final2022-01-06
mychelle dermaceuticals sun shield clearOTC monograph final2019-02-22
mychelle dermaceuticals sun shield clear spf 30OTC monograph final2022-01-07
mychelle dermaceuticals sun shield coconutOTC monograph final2019-02-25
mychelle dermaceuticals sun shield natural tanOTC monograph final2019-08-30
Show 15 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial eye infections—D015818—
bacterial infections—D001424A49
bacteroides infectionsEFO_1000832D001442—
haemophilus infectionsEFO_1001127D006192—
meningococcal meningitisEFO_1001040D008585A39.0
otitis externaEFO_0009560D010032H60
rickettsia infectionsEFO_1001162D012282A75-A79
salmonella infectionsEFO_1001418D012480A02.9
streptococcal infectionsEFO_1001476D013290—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06A: Antibiotics for topical use
— D06AX: Other antibiotics for topical use in atc
— D06AX02: Chloramphenicol
— D10: Anti-acne preparations
— D10A: Anti-acne preparations for topical use
— D10AF: Antiinfectives for treatment of acne
— D10AF03: Chloramphenicol
G: Genito urinary system and sex hormones
— G01: Gynecological antiinfectives and antiseptics
— G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
— G01AA: Antibiotics, gynecological
— G01AA05: Chloramphenicol
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01B: Amphenicols
— J01BA: Amphenicol antibacterials, systemic
— J01BA01: Chloramphenicol
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AA: Antibiotics, ophthalmologic
— S01AA01: Chloramphenicol
— S02: Otologicals
— S02A: Antiinfective drugs, otologic
— S02AA: Antiinfectives
— S02AA01: Chloramphenicol
— S03: Ophthalmological and otological preparations
— S03A: Antiinfectives, ophthalmologic and otologic
— S03AA: Antiinfectives
— S03AA08: Chloramphenicol
HCPCS
Code
Description
J0720
Injection, chloramphenicol sodium succinate, up to 1 gm
Clinical
Clinical Trials
18 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InflammationD007249MP_0001845————2—2
NecrosisD009336—————1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PneumoniaD011014EFO_0003106———1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dental pulp necrosisD003790—K04.1—1——12
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteomyelitisD010019EFO_0003102M861————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dry eye syndromesD015352—H04.12————22
CataractD002386HP_0000518H26.9————11
Patient reported outcome measuresD000071066——————11
Patient satisfactionD017060——————11
PterygiumD011625—H11.0————11
MycosesD009181—B35-B49————11
Corneal ulcerD003320—H16.0————11
Dental pulp diseasesD003788EFO_0009540K04————11
Bacterial infectionsD001424—A49————11
Surgical wound infectionD013530——————11
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameChloramphenicol
INNchloramphenicol
Description
Chloramphenicol is an organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions. It has a role as an antimicrobial agent, an antibacterial drug, a protein synthesis inhibitor, an Escherichia coli metabolite, a Mycoplasma genitalium metabolite and a geroprotector. It is an organochlorine compound, a diol, a C-nitro compound and a carboxamide.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl
Identifiers
PDB—
CAS-ID56-75-7
RxCUI—
ChEMBL IDCHEMBL130
ChEBI ID17698
PubChem CID5959
DrugBankDB00446
UNII ID66974FR9Q1 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Chloramphenicol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 124,129 documents
View more details
Safety
Black-box Warning
Black-box warning for: Chloramphenicol sodium succinate, Chloromycetin
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
537 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use